• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

多细胞相互作用维持人多能干细胞衍生心肌细胞的长期收缩性。

Multi-cellular interactions sustain long-term contractility of human pluripotent stem cell-derived cardiomyocytes.

作者信息

Burridge Paul W, Metzler Scott A, Nakayama Karina H, Abilez Oscar J, Simmons Chelsey S, Bruce Marc A, Matsuura Yuka, Kim Paul, Wu Joseph C, Butte Manish, Huang Ngan F, Yang Phillip C

机构信息

Stanford Cardiovascular Institute Palo Alto, CA ; Department of Medicine, Division of Cardiovascular Medicine Palo Alto, CA ; Institute for Stem Cell Biology and Regenerative Medicine Palo Alto, CA.

Stanford Cardiovascular Institute Palo Alto, CA ; Department of Medicine, Division of Pediatric Cardiology Palo Alto, CA.

出版信息

Am J Transl Res. 2014 Nov 22;6(6):724-35. eCollection 2014.

PMID:25628783
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC4297340/
Abstract

Therapeutic delivery of cardiomyocytes derived from human pluripotent stem cells (hPSC-CMs) represents a novel clinical approach to regenerate the injured myocardium. However, poor survival and contractility of these cells are a significant bottleneck to their clinical use. To better understand the role of cell-cell communication in enhancing the phenotype and contractile properties of hPSC-CMs, we developed a three-dimensional (3D) hydrogel composed of hPSC-CMs, human pluripotent stem cell-derived endothelial cells (hPSC-ECs), and/or human amniotic mesenchymal stem cells (hAMSCs). The objective of this study was to examine the role of multi-cellular interactions among hPSC-ECs and hAMSCs on the survival and long-term contractile phenotype of hPSC-CMs in a 3D hydrogel. Quantification of spontaneous contractility of hPSC-CMs in tri-culture demonstrated a 6-fold increase in the area of contractile motion after 6 weeks with characteristic rhythmic contraction frequency, when compared to hPSC-CMs alone (P < 0.05). This finding was supported by a statistically significant increase in cardiac troponin T protein expression in the tri-culture hydrogel construct at 6 weeks, when compared to hPSC-CMs alone (P < 0.001). The sustained hPSC-CM survival and contractility in tri-culture was associated with a significant upregulation in the gene expression of L-type Ca(2+) ion channel, Cav1.2, and the inward-rectifier potassium channel, Kir2.1 (P < 0.05), suggesting a role of ion channels in mediating these processes. These findings demonstrate that multi-cellular interactions modulate hPSC-CM phenotype, function, and survival, and they will have important implications in engineering cardiac tissues for treatment of cardiovascular diseases.

摘要

源自人多能干细胞的心肌细胞(hPSC-CMs)的治疗性递送代表了一种用于再生受损心肌的新型临床方法。然而,这些细胞的低存活率和收缩性是其临床应用的一个重大瓶颈。为了更好地理解细胞间通讯在增强hPSC-CMs的表型和收缩特性中的作用,我们开发了一种由hPSC-CMs、人多能干细胞衍生的内皮细胞(hPSC-ECs)和/或人羊膜间充质干细胞(hAMSCs)组成的三维(3D)水凝胶。本研究的目的是研究hPSC-ECs和hAMSCs之间的多细胞相互作用对3D水凝胶中hPSC-CMs的存活和长期收缩表型的作用。与单独培养的hPSC-CMs相比,三培养体系中hPSC-CMs的自发收缩性定量分析表明,6周后收缩运动面积增加了6倍,且具有特征性的节律性收缩频率(P < 0.05)。与单独培养的hPSC-CMs相比,三培养水凝胶构建体在6周时心肌肌钙蛋白T蛋白表达的统计学显著增加支持了这一发现(P < 0.001)。三培养体系中hPSC-CMs的持续存活和收缩性与L型Ca(2+)离子通道Cav1.2和内向整流钾通道Kir2.1的基因表达显著上调有关(P < 0.05),表明离子通道在介导这些过程中发挥作用。这些发现表明多细胞相互作用可调节hPSC-CMs的表型、功能和存活,并且它们将对用于治疗心血管疾病的心脏组织工程具有重要意义。

相似文献

1
Multi-cellular interactions sustain long-term contractility of human pluripotent stem cell-derived cardiomyocytes.多细胞相互作用维持人多能干细胞衍生心肌细胞的长期收缩性。
Am J Transl Res. 2014 Nov 22;6(6):724-35. eCollection 2014.
2
Effective Hypothermic Storage of Human Pluripotent Stem Cell-Derived Cardiomyocytes Compatible With Global Distribution of Cells for Clinical Applications and Toxicology Testing.人多能干细胞来源心肌细胞的有效低温保存,适用于细胞的全球分配以用于临床应用和毒理学测试。
Stem Cells Transl Med. 2016 May;5(5):658-69. doi: 10.5966/sctm.2015-0238. Epub 2016 Mar 29.
3
Cardiac muscle patches containing four types of cardiac cells derived from human pluripotent stem cells improve recovery from cardiac injury in mice.人心肌细胞贴片包含四种源自人类多能干细胞的人心肌细胞,可改善小鼠的心脏损伤恢复。
Cardiovasc Res. 2023 May 2;119(4):1062-1076. doi: 10.1093/cvr/cvad004.
4
Passive Stretch Induces Structural and Functional Maturation of Engineered Heart Muscle as Predicted by Computational Modeling.被动拉伸通过计算模型预测诱导工程心脏肌肉的结构和功能成熟。
Stem Cells. 2018 Feb;36(2):265-277. doi: 10.1002/stem.2732. Epub 2017 Nov 13.
5
Lessons from the heart: mirroring electrophysiological characteristics during cardiac development to in vitro differentiation of stem cell derived cardiomyocytes.从心脏中汲取的经验:在心脏发育过程中模拟电生理特征,以体外分化干细胞来源的心肌细胞。
J Mol Cell Cardiol. 2014 Feb;67:12-25. doi: 10.1016/j.yjmcc.2013.12.011. Epub 2013 Dec 23.
6
A Universal and Robust Integrated Platform for the Scalable Production of Human Cardiomyocytes From Pluripotent Stem Cells.一个用于从多能干细胞大规模生产人类心肌细胞的通用且强大的集成平台。
Stem Cells Transl Med. 2015 Dec;4(12):1482-94. doi: 10.5966/sctm.2014-0275. Epub 2015 Oct 28.
7
Contractility of single cardiomyocytes differentiated from pluripotent stem cells depends on physiological shape and substrate stiffness.源自多能干细胞的单个心肌细胞的收缩性取决于生理形状和底物硬度。
Proc Natl Acad Sci U S A. 2015 Oct 13;112(41):12705-10. doi: 10.1073/pnas.1508073112. Epub 2015 Sep 28.
8
Pluripotent stem cell-based cardiac regenerative therapy for heart failure.基于多能干细胞的心力衰竭心脏再生疗法。
J Mol Cell Cardiol. 2024 Feb;187:90-100. doi: 10.1016/j.yjmcc.2023.12.001. Epub 2024 Feb 6.
9
In Vitro Matured Human Pluripotent Stem Cell-Derived Cardiomyocytes Form Grafts With Enhanced Structure and Function in Injured Hearts.体外成熟的人多能干细胞衍生心肌细胞在受损心脏中形成具有增强结构和功能的移植物。
Circulation. 2022 May 3;145(18):1412-1426. doi: 10.1161/CIRCULATIONAHA.121.053563. Epub 2022 Jan 28.
10
Metabolic Maturation of Human Pluripotent Stem Cell-Derived Cardiomyocytes by Inhibition of HIF1α and LDHA.通过抑制 HIF1α 和 LDHA 实现人多能干细胞源性心肌细胞的代谢成熟
Circ Res. 2018 Oct 12;123(9):1066-1079. doi: 10.1161/CIRCRESAHA.118.313249.

引用本文的文献

1
Engineered heart tissue: Design considerations and the state of the art.工程化心脏组织:设计考量与当前技术水平
Biophys Rev (Melville). 2024 Jun 20;5(2):021308. doi: 10.1063/5.0202724. eCollection 2024 Jun.
2
Tissue-embedded stretchable nanoelectronics reveal endothelial cell-mediated electrical maturation of human 3D cardiac microtissues.组织嵌入可拉伸纳电子学揭示内皮细胞介导的人类 3D 心脏微组织的电成熟。
Sci Adv. 2023 Mar 10;9(10):eade8513. doi: 10.1126/sciadv.ade8513. Epub 2023 Mar 8.
3
Actin-microtubule cytoskeletal interplay mediated by MRTF-A/SRF signaling promotes dilated cardiomyopathy caused by LMNA mutations.肌动蛋白-微管细胞骨架相互作用通过 MRTF-A/SRF 信号传导促进由 LMNA 突变引起的扩张型心肌病。
Nat Commun. 2022 Dec 22;13(1):7886. doi: 10.1038/s41467-022-35639-x.
4
Bioengineering Strategies to Create 3D Cardiac Constructs from Human Induced Pluripotent Stem Cells.利用人类诱导多能干细胞构建三维心脏结构的生物工程策略
Bioengineering (Basel). 2022 Apr 10;9(4):168. doi: 10.3390/bioengineering9040168.
5
Sympathetic Neurons Regulate Cardiomyocyte Maturation in Culture.交感神经元在培养中调节心肌细胞成熟。
Front Cell Dev Biol. 2022 Mar 11;10:850645. doi: 10.3389/fcell.2022.850645. eCollection 2022.
6
Cardiac Tissue Engineering: Inclusion of Non-cardiomyocytes for Enhanced Features.心脏组织工程:纳入非心肌细胞以增强功能特性
Front Cell Dev Biol. 2021 May 25;9:653127. doi: 10.3389/fcell.2021.653127. eCollection 2021.
7
Next generation of heart regenerative therapies: progress and promise of cardiac tissue engineering.下一代心脏再生疗法:心脏组织工程的进展与前景
NPJ Regen Med. 2021 Jun 1;6(1):30. doi: 10.1038/s41536-021-00140-4.
8
Engineering Cardiovascular Tissue Chips for Disease Modeling and Drug Screening Applications.用于疾病建模和药物筛选应用的工程化心血管组织芯片
Front Bioeng Biotechnol. 2021 Apr 20;9:673212. doi: 10.3389/fbioe.2021.673212. eCollection 2021.
9
Generation, functional analysis and applications of isogenic three-dimensional self-aggregating cardiac microtissues from human pluripotent stem cells.从人类多能干细胞中生成、功能分析和应用同基因三维自聚集心脏微组织。
Nat Protoc. 2021 Apr;16(4):2213-2256. doi: 10.1038/s41596-021-00497-2. Epub 2021 Mar 26.
10
Toward a Microencapsulated 3D hiPSC-Derived Cardiac Microtissue for Recapitulation of Human Heart Microenvironment Features.迈向用于重现人类心脏微环境特征的微囊化三维人诱导多能干细胞衍生心脏微组织
Front Bioeng Biotechnol. 2020 Nov 5;8:580744. doi: 10.3389/fbioe.2020.580744. eCollection 2020.

本文引用的文献

1
Chemically defined generation of human cardiomyocytes.化学定义的人类心肌细胞生成。
Nat Methods. 2014 Aug;11(8):855-60. doi: 10.1038/nmeth.2999. Epub 2014 Jun 15.
2
The advancing field of cell-based therapy: insights and lessons from clinical trials.基于细胞疗法的前沿领域:来自临床试验的见解与经验教训。
J Am Heart Assoc. 2013 Oct 10;2(5):e000338. doi: 10.1161/JAHA.113.000338.
3
3D-culture system for heart regeneration and cardiac medicine.用于心脏再生和心脏医学的 3D 培养系统。
Biomed Res Int. 2013;2013:895967. doi: 10.1155/2013/895967. Epub 2013 Sep 8.
4
Screening drug-induced arrhythmia [corrected] using human induced pluripotent stem cell-derived cardiomyocytes and low-impedance microelectrode arrays.使用人诱导多能干细胞衍生的心肌细胞和低阻抗微电极阵列筛选药物诱导的心律失常[校正]。
Circulation. 2013 Sep 10;128(11 Suppl 1):S3-13. doi: 10.1161/CIRCULATIONAHA.112.000570.
5
Chemotaxis of human induced pluripotent stem cell-derived endothelial cells.人诱导多能干细胞衍生的内皮细胞的趋化性。
Am J Transl Res. 2013 Aug 15;5(5):510-20. eCollection 2013.
6
Human induced pluripotent stem cell-derived endothelial cells exhibit functional heterogeneity.人诱导多能干细胞衍生的内皮细胞表现出功能异质性。
Am J Transl Res. 2013;5(1):21-35. Epub 2013 Jan 21.
7
Heart disease and stroke statistics--2013 update: a report from the American Heart Association.《2013年心脏病和中风统计数据更新:美国心脏协会报告》
Circulation. 2013 Jan 1;127(1):e6-e245. doi: 10.1161/CIR.0b013e31828124ad. Epub 2012 Dec 12.
8
Passaging and colony expansion of human pluripotent stem cells by enzyme-free dissociation in chemically defined culture conditions.无酶消化法在化学成分确定的培养条件下传代和扩增人类多能干细胞。
Nat Protoc. 2012 Nov;7(11):2029-40. doi: 10.1038/nprot.2012.130. Epub 2012 Oct 25.
9
Extracellular matrix promotes highly efficient cardiac differentiation of human pluripotent stem cells: the matrix sandwich method.细胞外基质促进人多能干细胞高效的心脏分化:基质三明治法。
Circ Res. 2012 Oct 12;111(9):1125-36. doi: 10.1161/CIRCRESAHA.112.273144. Epub 2012 Aug 21.
10
2D and 3D-organized cardiac cells shows differences in cellular morphology, adhesion junctions, presence of myofibrils and protein expression.2D 和 3D 组织的心肌细胞在细胞形态、黏附连接、肌原纤维存在和蛋白表达方面存在差异。
PLoS One. 2012;7(5):e38147. doi: 10.1371/journal.pone.0038147. Epub 2012 May 25.